Presentation ACC 2024 A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy Presenter: James L. Januzzi Jr April 08, 2024
News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Conference News ACC 2023 Wrist-Worn Sensor May Help Detect Elevated Troponin in ACS L.A. McKeown March 06, 2023
News Conference News ACC 2022 DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF L.A. McKeown April 08, 2022
News Conference News ACC 2021 Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes Todd Neale May 16, 2021
News Conference News ACC 2021 Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients Shelley Wood May 16, 2021
News Conference News ACC 2019 Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being Yael L. Maxwell March 28, 2019
News Conference News ACC 2018 Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3 Shelley Wood March 16, 2018